More than 1.5 billion people around the world suffer from chronic
pain and it is one of the leading causes of patients seeking medical
care. Moreover, cost of pain comes to around USD 100 billion per year
which includes lost workdays and medical bills. The global pain
management therapeutics has observed healthy growth rate in the past and
has huge market potential in the future due to increase in the number
of population that suffers from medically significant pain. Other
drivers for this market include pain related to different tumors, low
back and post- operation. The expiry patent of anticonvulsant Lyrica and
anti-depressant Cymbalta in 2013 will also have significant impact on
the growth of this market.
In 2010, the post- operative pain relief market was the leading
segment, accounting for about 20% of the overall pain management
therapeutics market. The low back pain market was the second largest
segment followed by the neuropathic pain relief and cancer pain markets.
The market also consists of range of conditions such as postoperative
pain, arthritis pain, migraine pain, neuropathic pain, cancer pain, back
pain.
Some of the major players in this industry include Eli Lilly,
AstraZeneca PLC, Endo Pharmaceuticals, Johnson & Johnson, Novartis
Pharmaceuticals Corp, Glaxo Smithkline Plc, Merck & Co., Pfizer,
Inc., Purdue Pharma, Wyeth, and Sanofi S.A.
To
Buy a Copy Of This Report: www.marketresearchreports.biz/analysis-details/pain-management-therapeutics-market-global-industry-size-share-trends-analysis-and-forecast-2012-2018
This research report analyzes this market depending on its market
segments, major geographies, and current market trends. Geographies
analyzed under this research report include
- North America
- Asia Pacific
- Europe
- Rest of the World
This report provides comprehensive analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
This report is a complete study of current trends in the market,
industry growth drivers, and restraints. It provides market projections
for the coming years. It includes analysis of recent developments in
technology, Porter’s five force model analysis and detailed profiles of
top industry players. The report also includes a review of micro and
macro factors essential for the existing market players and new entrants
along with detailed value chain analysis.
Reasons for Buying this Report
- This report provides pin-point analysis for changing competitive dynamics
- It provides a forward looking perspective on different factors driving or restraining market growth
- It provides a technological growth map over time to understand the industry growth rate
- It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
- It helps in understanding the key product segments and their future
- It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
- It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
- It provides distinctive graphics and exemplified SWOT analysis of major market segments
Latest
Report:
Diammonium Hydrogen Phosphate
(DAP) Market - Global Industry Analysis, Size, Share, Growth, Trends, and
Forecast, 2012 – 2018: http://www.marketresearchreports.biz/analysis/166548
Diammonium hydrogen phosphate (DAP) is a type of water-soluble chemical
salt that releases ammonia and phosphoric acid and thus acts as a source of
nitrogen and phosphates. This ammonia and phosphate released on reaction with
water can temporarily increase th...
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
No comments:
Post a Comment